Javoy-Agid F - Search Results

1

Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.

Anglade P, Tsuji S, Javoy-Agid F, Agid Y, Hirsch EC. Anglade P, et al. Ann Neurol. 1995 Feb;37(2):265-72. doi: 10.1002/ana.410370219. Ann Neurol. 1995. PMID: 7847868

2

Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?

Kastner A, Hirsch EC, Lejeune O, Javoy-Agid F, Rascol O, Agid Y. Kastner A, et al. J Neurochem. 1992 Sep;59(3):1080-9. doi: 10.1111/j.1471-4159.1992.tb08350.x. J Neurochem. 1992. PMID: 1494900

3

Progressive supranuclear palsy: loss of choline-acetyltransferase-like immunoreactive neurons in the pontine reticular formation.

Malessa S, Hirsch EC, Cervera P, Javoy-Agid F, Duyckaerts C, Hauw JJ, Agid Y. Malessa S, et al. Neurology. 1991 Oct;41(10):1593-7. doi: 10.1212/wnl.41.10.1593. Neurology. 1991. PMID: 1922800

4

The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?

Agid Y, Graybiel AM, Ruberg M, Hirsch E, Blin J, Dubois B, Javoy-Agid F. Agid Y, et al. Adv Neurol. 1990;53:83-100. Adv Neurol. 1990. PMID: 1978522 Review. No abstract available.

5

Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study.

Javoy-Agid F, Hirsch EC, Dumas S, Duyckaerts C, Mallet J, Agid Y. Javoy-Agid F, et al. Neuroscience. 1990;38(1):245-53. doi: 10.1016/0306-4522(90)90389-l. Neuroscience. 1990. PMID: 1979431

6

Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study.

Thibaut F, Hirsch EC, Raisman R, Javoy-Agid F, Agid Y. Thibaut F, et al. Neuroscience. 1990;37(2):387-98. doi: 10.1016/0306-4522(90)90409-w. Neuroscience. 1990. PMID: 1983469

7

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.

Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y. Hirsch EC, et al. J Neurochem. 1991 Feb;56(2):446-51. doi: 10.1111/j.1471-4159.1991.tb08170.x. J Neurochem. 1991. PMID: 1988548

8

Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?

Hirsch EC, Duyckaerts C, Javoy-Agid F, Hauw JJ, Agid Y. Hirsch EC, et al. Ann Neurol. 1990 Jun;27(6):676-82. doi: 10.1002/ana.410270615. Ann Neurol. 1990. PMID: 2360804

9

Striatal dopamine deficiency in Parkinson's disease: role of aging.

Scherman D, Desnos C, Darchen F, Pollak P, Javoy-Agid F, Agid Y. Scherman D, et al. Ann Neurol. 1989 Oct;26(4):551-7. doi: 10.1002/ana.410260409. Ann Neurol. 1989. PMID: 2817829

10

Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography.

Lehéricy S, Brandel JP, Hirsch EC, Anglade P, Villares J, Scherman D, Duyckaerts C, Javoy-Agid F, Agid Y. Lehéricy S, et al. Brain Res. 1994 Oct 3;659(1-2):1-9. doi: 10.1016/0006-8993(94)90856-7. Brain Res. 1994. PMID: 7820649

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters